EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibacterial Potential of Actinomycete Extracts and Characterization of β‐Lactamase‐Producing Multidrug‐Resistant Uropathogenic Escherichia coli

Hoda Khaledi iD, Nour Oude Obeid

MicrobiologyOpen · 2025-12 · 14 (6)

DOI: 10.1002/mbo3.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 10.11.2025. Verfasst von Hoda Khaledi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Iranian National Institute for Oceanography and Atmospheric Science, Tehran, Iran. Hauptthemen laut MEDLINE: beta-Lactamases, Uropathogenic Escherichia coli, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of multidrug‐resistant (MDR) uropathogenic Escherichia coli (UPEC) strains, particularly those producing β‐lactamase enzymes, complicates urinary tract infection (UTI) treatment and poses a significant public health threat. This study investigates the antibacterial potential of actinomycete extracts against MDR UPEC isolates while characterizing their phylogenetic diversity and β‐lactamase profiles. From 300 clinical UTI samples collected in Babil Province, Iraq, 50 UPEC isolates were confirmed via standard microbiological and biochemical assays. Phylogenetic analysis, utilizing PCR‐based detection of chuA , yjaA , and TspE4.C2 loci, revealed that most isolates belonged to the virulent B2 group. Antibiotic susceptibility testing showed 64% of isolates were MDR, with high resistance to cephalosporins and fluoroquinolones. Screening for β‐lactamase genes identified bla CTX‐M‐I, bla TEM, and bla OXA as prevalent resistance determinants. Actinomycete isolates from soil samples produced ethyl acetate extracts that exhibited potent antibacterial effects against MDR UPEC, with inhibition zones exceeding 15 mm. These findings highlight actinomycetes as a promising source of novel antimicrobials to combat β‐lactamase‐producing UPEC, emphasizing the need for further compound characterization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesUropathogenic Escherichia coliAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialActinobacteriaHumansMicrobial Sensitivity TestsUrinary Tract InfectionsPhylogenyIraqEscherichia coli Infections

Stichwörter der Autor:innen

actinomycetesantibacterial agentsmultidrug‐resistant Escherichia coliphylogenetic analysisuropathogenic Infectionsβ‐lactamase

Substanzen

beta-LactamasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Iranian National Institute for Oceanography and Atmospheric Science, Tehran, Iran.
  • Department of Biology, College of Convergent Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran.

ORCID-Profile: Hoda Khaledi

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Khaledi, H., & Obeid, N. O. (2025). Antibacterial Potential of Actinomycete Extracts and Characterization of β‐Lactamase‐Producing Multidrug‐Resistant Uropathogenic Escherichia coli. MicrobiologyOpen, 14(6). https://doi.org/10.1002/mbo3.70143

Vancouver

Khaledi H, Obeid NO. Antibacterial Potential of Actinomycete Extracts and Characterization of β‐Lactamase‐Producing Multidrug‐Resistant Uropathogenic Escherichia coli. MicrobiologyOpen. 2025;14(6). doi:10.1002/mbo3.70143

BibTeX
@article{Khaledi2025,
  author = {Khaledi, Hoda and Obeid, Nour Oude},
  title = {Antibacterial Potential of Actinomycete Extracts and Characterization of β‐Lactamase‐Producing Multidrug‐Resistant Uropathogenic Escherichia coli},
  journal = {MicrobiologyOpen},
  year = {2025},
  volume = {14},
  number = {6},
  doi = {10.1002/mbo3.70143}
}
Kostenlos starten →